Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Guerrieri S, Rubin M, Gattuso I, Zanetta C, et al. Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series. J Neurol 2024 Apr 2. doi: 10.1007/s00415-024-12342.
PMID: 38564055


Privacy Policy